Clinical Trials Directory

Trials / Completed

CompletedNCT01968746

The AVERT Sepsis Investigation

The AVERT Sepsis Investigation: Assessment of Variability in Early Resuscitation and Treatment of Sepsis

Status
Completed
Phase
Study type
Observational
Enrollment
100 (actual)
Sponsor
Christiana Care Health Services · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The overall objective of this study is to utilize heart rate variability and respiratory rate variability in patients with sepsis to predict clinical deterioration and death. Our specific objectives are: 1. To study the ability of a change in composite variability (∆CVI) assessment to act as a prognostic aid in predicting disease progression in sepsis. 2. To study the effect that standard resuscitation interventions will have on the direction and magnitude of ∆CVI in patients with sepsis. B. Hypotheses H1: In the initial resuscitation of sepsis, a low or declining multi-parameter composite variability index (CVI) over 4 hours will predict a significant increase in the combined outcome of overt shock, organ dysfunction, and mortality. H2: In the initial resuscitation of sepsis, low volume fluid resuscitation (\<20 cc/kg) over 4 hours will be associated with a low or declining CVI.

Conditions

Timeline

Start date
2012-08-01
Primary completion
2015-01-01
Completion
2015-04-01
First posted
2013-10-24
Last updated
2016-07-11

Locations

5 sites across 2 countries: United States, Canada

Source: ClinicalTrials.gov record NCT01968746. Inclusion in this directory is not an endorsement.